Acute blood purification in various guidelines

Abstract

Since the introduction of hemodialysis for renal failure patients in the 20th century, acute blood purification has been applied to treat various critical illnesses. Here, we introduce the recently revised guidelines focusing on acute kidney injury (AKI), sepsis, and new coronavirus infections (coronavirus disease 2019: COVID-19). Regarding AKI, Kidney Disease Improving Global Outcomes (KDIGO) discussed the guidelines revision, recommending smooth communication with patients and the provision of renal replacement therapy (RRT) tailored to their condition. The Japanese sepsis guidelines have also been revised mainly about the timing of the introduction of RRT. As for COVID-19, various organizations have provided recommendations on RRT prescriptions, infection control, and circuit coagulation.